Burzynski Resh Institute (BZYR) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 71 90 sessions, October 8, 2025 to October 12, 2026
- Largest daily move
- +96.9% close of January 22, 2026
- 1-year change
- -99.5% closing prices, October 8, 2025 to October 12, 2026
- 1-month change
- -90% closing prices, September 3, 2026 to October 12, 2026
Company Description
Burzynski Resh Institute (OTC: BZYR) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $26.3K.
BZYR declined 99.5% in the 12 months to October 12, 2026. The last closing price was $0.0002.
For FY2025, Burzynski Resh Institute reported revenue of $0 and diluted earnings per share of -$0.01.
This page collects what Stock Titan holds for BZYR, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
Burzynski Resh Institute (BZYR) closed at $0.0002 on October 12, 2026. In the 12 months to October 12, 2026, the price lost 99.5%.
BZYR Metrics & Rankings
Price returns through October 12, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Burzynski Resh Institute has filed 5 recent SEC filings, including 2 Form 8-K, 2 Form 10-Q, 1 Form 8-K/A. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BZYR SEC filings →
Financial Highlights
Burzynski Resh Institute reported diluted earnings per share of -$0.01 in FY2025.
Upcoming Events
Short Interest History
Short interest in Burzynski Resh Institute (BZYR) currently stands at 285 shares, representing 0.0% of the float. Since November 2025, short interest has decreased by 86.1%.
Days to Cover History
Days to cover for Burzynski Resh Institute (BZYR) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
BZYR Company Profile & Sector Positioning
Burzynski Resh Institute (BZYR) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing BZYR often look at related companies in the same sector, including Braxia Scientific Corp (BRAXF), Universal Ibogaine Inc (IBOGF), Nascent Biotech Inc (NBIO), Carisma Therapeutics Inc (CARM), and Windtree Therapeutics New (WINT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BZYR's relative position within its industry.